LR Pharma

Active

Private limited companyfounded 20242 years activeSchaapsdreef(Kor) 3, 8500 Kortrijk, BelgiumKBO/BCE: BE 1013.896.656

Summary

LR Pharma has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €17,908 and a net result of €15,741. Its solvency ranks better than 49% of 9,489 sector peers (NACE 82, fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisWatch Report Compare

LR PharmaActiveChecked score 92/100

Risk analysis Report Compare

Activity

Other business support services

NACE 82990

1 site

Size

€35,859total assets 2025

Equity: €17,908
Profit: €15,741

Turnover not published (abridged schema)

Financial health

92 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: 0.2%

Structure

Accounts 43 days early0 of 1 deed read

Why 92- Size: total assets €35,859- Founded in 2024+ Sector Office administrative, office support and other business support activities (NACE 82)+ Liquidity: current ratio 1.88, cash €19,104Show the evidence

Checked score

Score 2025

92 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 69% of its sector peers (NACE 82, micro)

Every signal that weighs is under Signals.

Financial strength

Strong

Solvency 75

equity 49.9% of total assets

Liquidity 75

short-term debt 50.1% · cash 53.3%

Profitability 100

return on assets 43.9%

Bankruptcy probability, 12 months

0.2% Very low

0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (12,604 companies)

Last 24 months 10-2025: 0.6% 11-2025: 0.6%● unchanged vs 10-2025 12-2025: 0.6%● unchanged vs 11-2025highest value 01-2026: 0.1%▼ -0.5 percentage points vs 12-2025lowest value 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.2%▲ +0.1 percentage points vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026

Credit up to €1,500 at 30 days acceptable

Liquidity ample (current ratio 1.88; short-term debt: 50.1% and cash: 53.3% of total assets), but 50.1% of the assets are financed with debt.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 82, micro): better than 51% on solvency, 69% on liquidity and 87% on profitability.

The bankruptcy probability was computed on 07-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.